AI-generated summary
The authors reviewed published in vitro studies of human mesenchymal cells treated with photobiomodulation at wavelengths from 600 to 1000 nm. From 37 selected articles, they report that most procedures measured cell proliferation, and they describe photobiomodulation as a promising technology that may affect cell viability, differentiation, proliferation, or migration.
- Studies included
- 37
- Who or what was studied
- Human mesenchymal cells studied in vitro (laboratory cell cultures), from articles found in a PubMed search
- Wavelengths
- 600, 1000 nm
- Limits stated in the abstract
- The review covers only in vitro cell studies, not clinical outcomes in patients, and the abstract does not assess the quality or certainty of the included studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 600 to 1000 nm, 620 to 625 nm, 625 to 740 nm, 740 to 1000 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Angiogenesis, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.